South African regulator says no major safety concerns from local J&J study

CAPE TOWN, April 14 (Reuters) - South Africa's drugs regulator SAHPRA said on Wednesday that it had recently reviewed data from Johnson & Johnson's (J&J) (JNJ.N) local research study immunising healthcare workers and found no major safety concerns.

SAHPRA added that it was awaiting additional data from J&J and the U.S. Food and Drug Administration.

South Africa suspended the rollout of the J&J vaccine in the "implementation study" on Tuesday, after U.S. health agencies recommended pausing its use because of rare cases of blood clots in six people inoculated with it. read more

Reporting by Wendell Roelf Editing by Alexander Winning

Our Standards: The Thomson Reuters Trust Principles.